Diff for "Funding" - Bader Lab @ The University of Toronto

Differences between revisions 70 and 72 (spanning 2 versions)

Funding Agency		Title	Grant Period
	Canadian Cancer Society	Reimagining glioblastoma as a consequence of aberrant neural tissue repair Pl: Peter Dirks	2020-2024
	U.S. NIH via National Center for Research Resources (NCRR)	National Resource for Network Biology (NRNB), PIs: Trey Ideker, Chris Sander, Alex Pico, Gary Bader. This work was supported by NRNB (U.S. National Institutes of Health, National Center for Research Resources grant number P41 GM103504)	2010-2025
	U.S. NIH via National Institute of General Medical Sciences (NIGMS)	Cytoscape: A Modeling Platform for Biomolecular Networks Funding for continued development and maintenance of Cytoscape is provided by the U.S. National Human Genome Research Institute (NHGRI) under award number HG009979. Cytoscape user support, education and new initiatives are supported by the National Resource for Network Biology (NRNB) under award numbers P41 RR031228 and GM103504. PIs: Trey Ideker, Gary Bader.	2004-2021
	University of Manitoba	Integrated multi-omic delineation of SARS-CoV-2-dysregulated cellular processes Pl: Kevin Coombs	2020-2021
	National Research Council Canada	AI for Precision Discovery on Associations in Biological Systems Spon Ref: AI4D-109-1 Pl: Xiaojian Shao, Youlian Pan	2020-2021
	Chan Zuckerberg Initiative	A reference cell atlas of human liver diversity of a lifespan Spon Ref: 235319 PI: Alan Mullen	2019-2021
	Canada First Research Excellence Fund	Stem cell based approaches to endogenous repair of brain and skeletal muscle Spon Ref::MBDC2-2019-02 PI's: Freda Miller, Alison McGuigan, Peter Zandstra, Penny Gilbert, Sidhartha Goyal, Cindi Morshead, Yun Li, David Kaplan	2019-2020
	Canada First Research Excellence Fund	Investigating how age-related clonal hematopoiesis drives HSC stemness properties ane how this leads to inflammatory disease of the heart Pl: John Dick	2019-2020
	Canada First Research Excellence Fund	Development of novel cell and tissue therapies to treat liver failure Pl: Gordon Keller	2019-2020
	Ontario Institute for Cancer Research	Cellular and Genetic Heterogeneity as a Therapeutic Hurdle and Opportunity for Ontarians with Brain Cancer (Operating Grant) Pl: Peter Dirks	2017-2021
	Ontario Institute for Cancer Research	Acute Leukemia Translational Initiative (Operating Grant) Pl: John Dick	2017-2021
	Canada Foundation for Innovation	The Cancer Genome Collaboratory Pl: Lincoln Stein The authors wish to acknowledge the funding support of the Canada Foundation for Innovation Cyberinfrastructure Initiative, the Ontario Research Fund, BC Knowledge Development Fund and the Ministère de l'Économie, de la Science et l'Innovation for 'The Cancer Genome Collaboratory' project	2016-2022
	Natural Sciences and Engineering Research Council of Canada	Cell and tissue communication networks Pl: Gary Bader	2016-2021
	Canada First Research Excellence Fund	Overcoming Blindness: Differentiation, Purification and Transplantation of Photoreceptors (Operational sub-grant). PI: Molly Shoichet. Funder acknowledgement statement: "This research was undertaken thanks in part to funding provided to the University of Toronto Medicine by Design initiative, by the Canada First Research Excellence Fund.”	2016-2019
	Canada First Research Excellence Fund	Regulatory network control of neural stem cells for endogenous repair (Operating Grant: C1TPA-2016-01). PIs: Gary Bader, Freda Miller, David Kaplan, Derek van der Kooy, Michael Moran, Aaron Wheeler, Cindi Morshead, Quaid Morris, Michael Hoffman, Lincoln Stein, Sidhartha Goyal, Trevor Pugh, Michael Wilson. Funder acknowledgement statement: "This research was undertaken thanks in part to funding provided to the University of Toronto Medicine by Design initiative, by the Canada First Research Excellence Fund.”	2016-2019
	Canada First Research Excellence Fund	Pathways to enhance the clinical utility of hematopoietic stem cell transplantation (Operating Grant: C1TPA-2016-02). PIs: John Dick, Norman Iscove, Mathieu Lupien, Gary Bader, Quaid Morris, Igor Jurisica, Shana Kelley. Funder acknowledgement statement: "This research was undertaken thanks in part to funding provided to the University of Toronto Medicine by Design initiative, by the Canada First Research Excellence Fund.”	2016-2019
	Canadian Institutes of Health Research	From correlation to causation in genomics: identifying mechanisms underlying disease (Foundation Grant) Pl: Gary Bader	2015-2022
	The Terry Fox Research Institute	Development of Stemness-based Prognostic Biomarkers and Therapeutic Targets(Operating Grant: 1047) Pl: John Dick	2015-2020
	U.S. NIH	A human binary interactome reference map by 2020 (Operational sub-grant:U41-HG001715-18). PIs: Marc Vidal, Michael Calderwood, David Hill, Frederick Roth.	2015-2018
	Stand Up To Cancer	Targeting brain tumour stem cell epigenetic and molecular networks (Operating Sub-Grant: SU2C-AACR-DT-19-15) Pls: Peter Dirks, Samuel Weiss, Michael Taylor, Nada Jabado, Cheryl Arrowsmith, Michael Salter, Marco Marra, Mathieu Lupien, Amy Caudy, Trevor Pugh, Gary Bader, Michael Tyers, Wendy Durigon, Warren Mason, Eric Bouffet.	2015-2019
	Natural Sciences and Engineering Research Council of Canada	The Cancer Genome Collaboratory (Operating Grant: Discovery Frontiers) Pls: Lincoln Stein, Gary Bader, Alexandre Bouchard- Cote, Gillaume Bourque, Paul Boutros, Khaled El Emam, Vincent Ferretti, Bartha Knoppers, Francis Ouellette, Cenk Sahinalp, Sohrab Shah, Brian Shoichet.	2014-2018
	Ontario Institute for Cancer Research	Cancer stem cell program (Operating Grant) Pl: John Dick	2013-2017
	Genome Canada	Personalised Risk Stratification for Prevention and Early Detection of Breast Cancer (Operating Sub-Grant) Pls: Bartha Maria Knoppers, and Jacques Simard.	2013-2017
	U.S. NIH via National Human Genome Research Institute (NHGRI)	Pathway Commons Research resource for biological pathways. Pathway Commons is a collaboration between the Bader Lab at the University of Toronto, the Sander Lab at the cBio Center for Information Biology, Dana-Farber Cancer Institute and the Computational biology collaboratory at Harvard Medical School, and the Demir Lab, Oregon Health & Science University (Grant: U41 HG006623).	2008-2018
	Canadian Institutes of Health Research	A computational and experimental approach to map and evolutionary analyze protein interactions mediated by peptide recognition domains (Operating Grant MOP-84324) Pl: Gary Bader	2007-2017
	U.S. NIH	Knowledge-based Gene Expression Analysis for Biomedical and Cancer Research (Operating Sub-Grant: 69119295) PIs: Jill Mesirov and Gary Bader.	2006-2017

-  ⇤ ← Revision 70 as of 2020-11-11 21:15:47 → 
  Size: 10043
  Editor: AnnaCorpuz
  Comment:
+   ← Revision 72 as of 2021-04-28 18:09:42 → ⇥
  Size: 10341
  Editor: AnnaCorpuz
  Comment:
-Deletions are marked like this.
+Additions are marked like this.
 Line 4:
-||<style="text-align: center;">{{attachment:nih.gif}}||[[http://www.nih.gov/|U.S. NIH]] via [[http://www.ncrr.nih.gov/|National Center for Research Resources (NCRR)]]||[[http://nrnb.org/|National Resource for Network Biology (NRNB)]], PIs: Trey Ideker, Chris Sander, Alex Pico, Gary Bader.<<BR>><<BR>>This work was supported by NRNB (U.S. National Institutes of Health, National Center for Research Resources grant number P41 GM103504)||2020--2025||
||<style="text-align: center;">{{attachment:nih.gif}}||[[http://www.nih.gov/|U.S. NIH]] via [[http://www.nigms.nih.gov/|National Institute of General Medical Sciences (NIGMS)]]||[[http://www.cytoscape.org/|Cytoscape: A Modeling Platform for Biomolecular Networks]]<<BR>><<BR>>Funding for continued development and maintenance of Cytoscape is provided by the U.S. National Human Genome Research Institute (NHGRI) under award number HG009979.<<BR>><<BR>>Cytoscape user support, education and new initiatives are supported by the National Resource for Network Biology (NRNB) under award numbers P41 RR031228 and GM103504.<<BR>><<BR>>PIs: Trey Ideker, Gary Bader.||2020-2025||
+||<style="text-align:center;">{{attachment:CCS.PNG||width=150}}||[[ https://www.cancer.ca/en/get-involved/events-and-participation/home-march/?region=on |Canadian Cancer Society]]||Reimagining glioblastoma as a consequence of aberrant neural tissue repair  <<BR>><<BR>>Pl: Peter Dirks||2020-2024||
||<style="text-align: center;">{{attachment:nih.gif}}||[[http://www.nih.gov/|U.S. NIH]] via [[http://www.ncrr.nih.gov/|National Center for Research Resources (NCRR)]]||[[http://nrnb.org/|National Resource for Network Biology (NRNB)]], PIs: Trey Ideker, Chris Sander, Alex Pico, Gary Bader.<<BR>><<BR>>This work was supported by NRNB (U.S. National Institutes of Health, National Center for Research Resources grant number P41 GM103504)||2010-2025||
||<style="text-align: center;">{{attachment:nih.gif}}||[[http://www.nih.gov/|U.S. NIH]] via [[http://www.nigms.nih.gov/|National Institute of General Medical Sciences (NIGMS)]]||[[http://www.cytoscape.org/|Cytoscape: A Modeling Platform for Biomolecular Networks]]<<BR>><<BR>>Funding for continued development and maintenance of Cytoscape is provided by the U.S. National Human Genome Research Institute (NHGRI) under award number HG009979.<<BR>><<BR>>Cytoscape user support, education and new initiatives are supported by the National Resource for Network Biology (NRNB) under award numbers P41 RR031228 and GM103504.<<BR>><<BR>>PIs: Trey Ideker, Gary Bader.||2004-2021||
-Line 16:
+Line 17:
-||<style="text-align: center;">{{attachment:cfref.png||width=150}}||[[http://www.cfref-apogee.gc.ca/home-accueil-eng.aspx/| Canada First Research Excellence Fund]]||Overcoming Blindness: Differentiation, Purification and Transplantation of Photoreceptors (Operational sub-grant). <<BR>><<BR>> PI: Molly Shoichet.<<BR>><<BR>>Funder acknowledgement statement: "This research was undertaken thanks in part to funding provided to the University of Toronto Medicine by Design initiative, by the Canada First Research Excellence Fund.”||2016-2019||
+||<style="text-align: center;">{{attachment:cfref.png||width=170}}||[[http://www.cfref-apogee.gc.ca/home-accueil-eng.aspx/| Canada First Research Excellence Fund]]||Overcoming Blindness: Differentiation, Purification and Transplantation of Photoreceptors (Operational sub-grant). <<BR>><<BR>> PI: Molly Shoichet.<<BR>><<BR>>Funder acknowledgement statement: "This research was undertaken thanks in part to funding provided to the University of Toronto Medicine by Design initiative, by the Canada First Research Excellence Fund.”||2016-2019||